Apellis Pharmaceuticals (APLS stock) price chart shows headwinds and fell from the high of $90, made a double bottom pattern, and initiated a correction in the past sessions. Moreover, APLS stock retested the support zone of $20 and is slowly & steadily recovering. Furthermore, the price action shows buyers’ accumulation. APLS stock is hovering in the neutral zone thanks to short covering moves.
APLS stock price is trying to sustain above the 20-day EMA and looking to surpass the 200-day EMA hurdle beyond the cluster of $50. Furthermore, there is a gap near $70, and APLS share price will soon fill the remaining gap and pick up momentum beyond it. However, the chart structure was destroyed and did not give any signs of bullishness, and bulls lacked momentum in the past few sessions.
At press time, APLS stock price was trading at $43.77 with an intraday drop of 6.87%, showing rejection from the 50-day EMA. Moreover, the trading volume increased by 1.23% to 3.272 Million, and the market cap is $5.153 Billion. Furthermore, analysts maintained a neutral rating with a yearly target price of $67.64, suggesting a growth outlook for the following sessions.
Apellis Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel therapeutic compounds to treat diseases with high unmet needs. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009, and is headquartered in Waltham, MA.
APLS Stock Price Action on Daily Charts
On the daily charts, APLS stock price was trading in the neutral zone showing a reversal from the lows of $20, suggesting that the correction was over and fresh buying momentum was witnessed over the past trading sessions. However, the price action shows strong rejection from the 50-day EMA, APLS share price again fell toward the 20-day EMA. Furthermore, the price is above the 50% Fib zone but failed to sustain beyond the 61.8% level, showing a strong supply zone there.
The RSI curve stayed in the overbought zone, showing a bullish divergence, suggesting that an upswing to the $70 mark can be anticipated in the coming sessions.
The MACD showed a bullish crossover and formed green bars on the histogram, suggesting a positive outlook for the following sessions.
Summary
APLS stock price is trading near neutrality and retained the strength by sustaining on the 20-day EMA. Moreover, the price action suggests that buyers continue accumulating and are persistent in making long build-ups, showing their willingness to reach the $50 mark. Furthermore, the chart showcased a gap near $70, which bulls look to fill soon.
Technical Levels
Support Levels:$40 and $30
Resistance Levels: $50 and $65
Disclaimer
The views and opinions stated by the author or any other person named in this article are for informational purposes only and do not constitute financial, investment, or other advice. Investing in or trading crypto or stocks comes with a risk of financial loss.
Source: https://www.thecoinrepublic.com/2023/09/23/apls-stock-nasdaqapls-recovers-will-it-sustain-at-50/